Stock 0NF0 MYDECINE INNOVATIONS GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Mydecine Innovations Group Inc. Deutsche Boerse AG

Equities

0NF0

CA62849F2008

Delayed Deutsche Boerse AG
Other stock markets
 02:04:24 2024-04-26 am EDT 		5-day change 1st Jan Change
0.01 EUR -4.76% Intraday chart for Mydecine Innovations Group Inc. -16.67% -23.08%
Feb. 23 Mydecine Innovations Closes Partial Debt Settlement MT
Feb. 02 Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Mydecine Innovations Group Inc. Announces Share for Debt Settlement
AQ
Mydecine Innovations Closes Partial Debt Settlement
MT
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
GL
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
AQ
Mydecine Innovations Group Announces Director Resignation
GL
Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director
CI
Mydecine Innovations Group Receives Notice of Allowance from USPTO For MYCO-005 Compound
MT
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
GL
Mydecine Announces Update Regarding the Special Access Program
GL
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements
GL
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements
AQ
Mydecine Innovations Group Provided Q4 2023 Business Update
MT
Mydecine Provides Q4 2023 Business Update
GL
Mydecine Provides Q4 2023 Business Update
AQ
Mydecine Innovations Group gearing up for human trials after completing Aquis listing
AQ
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK
GL
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK
AQ
Mydecine Innovations Group Brief: Announced Admission to Trading on AQSE Growth Market in London, UK and First Day of Dealings
MT
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MYCOF Stock
  4. 0NF0 Stock
  5. News Mydecine Innovations Group Inc.